Study Of Marketing Strategy For SHKB Company’s NDB Prescription Drugs

SHKB company is a pharmaceutical enterprise, which mainly manufacture cardiovascular prescription drugs, NDB for injection is ever company’s key product. It was ceased to manufacture because of national policy in December2008, now it has been gained the qualification for manufacture and market again.In this paper, thereby making the marketing strategy, such as the distribution model, pricing, channel selection and control,marketing communication, and to standardize the internal sales system and to cooperate with other departments to ensure the smooth implementation of strategy by the application of the theory of marketing knowledge, combined with cardiovascular and cerebrovascular prescription drug market demand and the company’s strengths and weaknesses in the current marketing environment. We suggest the company to take both part of the regional general agent system, academic promotion+office promotion and agent distribution model, for different drug bidding area, such as have won, not opening and not tender area, can select different pricing policy, scientific evaluate company’s agents, definite their responsibilities and rights,then can combine the interests of agents and the interests of the company to a high degree of unity, to select and control the marketing channel, and through the image advertisements and public service advertisements, strengthening the corporate public relations ability, make full use of the Internet platform to brand plastic, through strengthening and standardizing academic sponsorship, and clinicians are fully technology exchange, communicate emotion marketing perspective to establish and maintain with the hospital, and patients with active and interactive measures such as marketing communication marketing strategy, and points out the normative internal sales system and cooperate with other departments to ensure the measures, strategies to shun and Implementation.